

浏览全部资源
扫码关注微信
郑州人民医院乳腺科,河南 郑州 450053
ZHANG Jingchen
Received:06 January 2022,
Revised:2022-03-25,
Published:30 September 2022
移动端阅览
Jingchen ZHANG, Xin LI, Jiangtao LI, et al. LINC02163 targeting miR-338-3p affects proliferation, invasion and migration of breast cancer cells[J]. China Oncology, 2022, 32(9): 818-826.
Jingchen ZHANG, Xin LI, Jiangtao LI, et al. LINC02163 targeting miR-338-3p affects proliferation, invasion and migration of breast cancer cells[J]. China Oncology, 2022, 32(9): 818-826. DOI: 10.19401/j.cnki.1007-3639.2022.09.009.
背景与目的:
长链非编码RNA(long non-coding RNA
lncRNA)已被发现在乳腺癌中失调
与肿瘤恶性行为密切相关。本研究旨在探究LINC02163靶向miR-338-3p对乳腺癌细胞增殖、侵袭及迁移的影响。
方法:
收集郑州人民医院2020年1月
&
#x02014;2021年9月收治的9例乳腺癌患者的乳腺癌组织及距其2 cm外的癌旁组织样本
通过实时荧光定量聚合酶链反应(real-time fluorescence quantitative polymerase chain reaction
RTFQ-PCR)检测组织样本、人正常乳腺上皮细胞系(MCF-10A)和乳腺癌细胞系(MCF-7、BT-20、MDA-MB-231、T47D)中LINC02163的表达。将MDA-MB-231分为control组、sh-NC组、sh-LINC02163组、sh-LINC02163+inhibitor-NC组和sh-LINC02163+miR-338-3p inhibitor组。采用MTT法、transwell实验及划痕实验分别检测MDA-MB-231细胞活力、侵袭及迁移能力。采用蛋白质印迹法(Western blot)检测MDA-MB-231细胞c-Myc、基质金属蛋白酶(matrix metalloproteinase
MMP)2、MMP9、E-钙粘素(E-cadherin)及N-钙粘素(N-cadherin)蛋白的表达。通过双荧光素酶报告基因实验分析LINC02163与miR-338-3p的靶向关系。采用体内成瘤实验检测BALB/c裸鼠肿瘤体积及重量。采用免疫组织化学法检测裸小鼠移植瘤组织的Ki-67增殖指数。
结果:
与癌旁组织相比
LINC02163在乳腺癌组织中的表达显著升高(
P
<
0.05)。与MCF-10A细胞相比
LINC02163在MCF-7、BT-20、MDA-MB-231及T47D细胞中的表达均显著升高
并且其在MDA-MB-231细胞中升高最为显著(
P
<
0.05)。与control组比
sh-LINC02163组LINC02163表达、细胞存活率、侵袭细胞数及迁移率、c-Myc、MMP2、MMP9、N-cadherin表达、肿瘤体积及重量、Ki-67增殖指数显著降低
miR-338-3p、E-cadherin表达显著升高(
P
<
0.05)。与sh-LINC02163组相比
sh-LINC02163+miR-338-3p inhibitor组LINC02163表达无显著变化(
P
>
0.05)
细胞存活率、侵袭细胞数及迁移率、c-Myc、MMP2、MMP9、N-cadherin表达、肿瘤体积及重量、Ki-67增殖指数显著增加
miR-338-3p、E-cadherin表达显著降低(
P
<
0.05)。在乳腺癌中LINC02163与miR-338-3p存在潜在的靶向关系。
结论:
沉默LINC02163表达通过促进miR-338-3p表达来抑制乳腺癌细胞增殖、侵袭及迁 移。
Background and purpose:
Long non-coding RNA (lncRNA) has been found to be dysregulated in breast cancer and is closely related to the malignant behavior of tumors. This study aimed to explore the effects of LINC02163 targeting miR-338-3p on the proliferation
invasion and migration of breast cancer cells.
Methods:
Breast cancer tissue samples and the adjacent tissue samples (2 cm to cancer tissue) were collected from 9 female breast cancer patients admitted to People
&
#x02019;s Hospital of Zhengzhou
from January 2020 to September 2021. Real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR) was used to detect the expression of LINC02163 in tissue samples
human normal breast epithelial cell line (MCF-10A) and breast cancer cell lines (MCF-7
BT-20
MDA-MB-231
T47D). MDA-MB-231 was divided into control group
sh-NC group
sh-LINC02163 group
sh-LINC02163+inhibitor-NC group and sh-LINC02163+miR-338-3p inhibitor group. MTT method
transwell test and scratch test were used to detect the MDA-MB-231 cell viability
invasion and migration ability. Western blot was used to detect the protein expression of c-Myc
matrix metalloproteinase (MMP) 2
MMP9
E-cadherin and N-cadherin in MDA-MB-231 cells. Dual luciferase reporter gene was used to detect the targeting relationship between LINC02163 and miR-338-3p. In vivo tumor formation experiment was used to detect tumor volume and weight in nude mice. Immunohistochemical method was used to detect the Ki-67 proliferation index in tumor tissues of BALB/c nude mice.
Results:
Compared with adjacent tissues
the expression of LINC02163 in breast cancer tissues was significantly higher (
P
<
0.05). Compared with MCF-10A cells
the expression of LINC02163 in MCF-7
BT-20
MDA-MB-231 and T47D cells was significantly higher
and it increased most significantly in MDA-MB-231 cells (
P
<
0.05). Compared with the control group
the LINC02163 expression
cell survival rate
number of invasive cells
migration rate
expressions of c-Myc
MMP2
MMP9 and N-cadherin
tumor volume and weight
and Ki-67 proliferation index were significantly reduced in the sh-LINC02163 group
while the expressions of miR-338-3p and E-cadherin were significantly increased (
P
<
0.05). Compared with the sh-LINC02163 group
the expression of LINC02163 in the sh-LINC02163+miR-338-3p inhibitor group did not change significantly (
P
>
0.05)
the cell survival rate
number of invasive cells
migration rate
expressio
ns of c-Myc
MMP2
MMP9 and N-cadherin
tumor volume and weight
and Ki-67 proliferation index were significantly increased
while the expressions of miR-338-3p and E-cadherin were significantly reduced (
P
<
0.05). LINC02163 had a potential targeting relationship with miR-338-3p in breast cancer.
Conclusion:
Silencing the expression of LINC02163 can inhibit the proliferation
invasion and migration of breast cancer cells by promoting the expression of miR-338-3p.
LIANG Y R , SONG X J , LI Y M , et al . LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis [J ] . Mol Cancer , 2020 , 19 ( 1 ): 85 . DOI: 10.1186/s12943-020-01206-5 http://doi.org/10.1186/s12943-020-01206-5
ZHAO W Y , GENG D H , LI S Q , et al . LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer [J ] . Cancer Med , 2018 , 7 ( 3 ): 842 - 855 . DOI: 10.1002/cam4.1353 http://doi.org/10.1002/cam4.1353 https://onlinelibrary.wiley.com/doi/10.1002/cam4.1353 https://onlinelibrary.wiley.com/doi/10.1002/cam4.1353
SHEN Y , PENG X W , SHEN C L . Identification and validation of immune-related lncRNA prognostic signature for breast cancer [J ] . Genomics , 2020 , 112 ( 3 ): 2640 - 2646 . DOI: S0888-7543(20)30065-3 http://doi.org/S0888-7543(20)30065-3
QIN C L , JIN L F , LI J , et al . Long noncoding RNA LINC 02163 accelerates malignant tumor behaviors in breast cancer by regulating the microRNA-511-3p/HMGA2 axis [J ] . Oncol Res , 2020 , 28 ( 5 ): 483 - 495 . DOI: 10.3727/096504020X15928179818438 http://doi.org/10.3727/096504020X15928179818438 https://www.ingentaconnect.com/content/10.3727/096504020X15928179818438 https://www.ingentaconnect.com/content/10.3727/096504020X15928179818438
TIAN Y , ZHOU J , ZOU Y F , et al . Upregulated long noncoding RNAs LINC02163 and FEZF1-AS1 exert oncogenic roles in colorectal cancer [J ] . Anticancer Drugs , 2021 , 32 ( 1 ): 66 - 73 . DOI: 10.1097/CAD.0000000000000975 http://doi.org/10.1097/CAD.0000000000000975 https://journals.lww.com/10.1097/CAD.0000000000000975 https://journals.lww.com/10.1097/CAD.0000000000000975
HE J J , WANG J , LI S C , et al . Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2 [J ] . Cancer Sci , 2020 , 111 ( 10 ): 3550 - 3563 . DOI: 10.1111/cas.14589 http://doi.org/10.1111/cas.14589 https://onlinelibrary.wiley.com/doi/10.1111/cas.14589 https://onlinelibrary.wiley.com/doi/10.1111/cas.14589
周大为 , 朱征涛 , 靳明明 , 等 . hsa_circ_0070260靶向miR-27a-3p/Fbxw7对乳腺癌增殖,侵袭调控研究 [J ] . 重庆医学 , 2020 , 49 ( S1 ): 24 - 28 .
ZHOU D W , ZHU Z T , JI M M , et al . hsa_circ_0070260/miR-27a-3p/Fbxw7 regulates the proliferation and migration of breast cancer cells [J ] . Chongqing Med , 2020 , 49 ( S1 ): 24 - 28 .
MILLER K D , NOGUEIRA L , MARIOTTO A B , et al . Cancer treatment and survivorship statistics, 2019 [J ] . CA A Cancer J Clin , 2019 , 69 ( 5 ): 363 - 385 . DOI: 10.3322/caac.21565 http://doi.org/10.3322/caac.21565 https://onlinelibrary.wiley.com/doi/abs/10.3322/caac.21565 https://onlinelibrary.wiley.com/doi/abs/10.3322/caac.21565
XIU B Q , CHI Y Y , LIU L , et al . LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription [J ] . Mol Cancer , 2019 , 18 ( 1 ): 187 . DOI: 10.1186/s12943-019-1115-y http://doi.org/10.1186/s12943-019-1115-y
SHI Q F , LI Y D , LI S Y , et al . LncRNA DILA1 inhibits cyclin D1 inhibits cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer [J ] . Nat Commun , 2020 , 11 : 5513 . DOI: 10.1038/s41467-020-19349-w http://doi.org/10.1038/s41467-020-19349-w https://doi.org/10.1038/s41467-020-19349-w https://doi.org/10.1038/s41467-020-19349-w
DONG L M , HONG H S , CHEN X W , et al . LINC02163 regulates growth and epithelial-to-mesenchymal transition phenotype via miR-593-3p/FOXK1 axis in gastric cancer cells [J ] . Artif Cells Nanomed Biotechnol , 2018 , 46 ( sup2 ): 607 - 615 . DOI: 10.1080/21691401.2018.1464462 http://doi.org/10.1080/21691401.2018.1464462
MA J W , ZHANG L H , SHANG A Q , et al . LINC02163 promotes colorectal cancer progression via miR-511-3p/AKT3 axis [J ] . Artif Cells Nanomed Biotechnol , 2020 , 48 ( 1 ): 961 - 968 . DOI: 10.1080/21691401.2020.1773486 http://doi.org/10.1080/21691401.2020.1773486
罗毅 , 房晓瑜 , 谢薇佳 , 等 . 长链非编码RNA LINC02163在肝细胞肝癌中表达上调并促进肝癌细胞迁移和侵袭 [J ] . 第三军医大学学报 , 2020 , 42 ( 1 ): 81 - 87 .
LUO Y , FANG X Y , XIE W J , et al . Long non-coding RNA LINC02163 is up-regulated and promotes cell migration and invasion in hepatocellular carcinoma [J ] . J Third Mil Med Univ , 2020 , 42 ( 1 ): 81 - 87 .
来旭 , 范亚楠 , 王瑞丰 . LINC01106靶向miR-744-5p影响乳腺癌MDA-MB-231细胞增殖、迁移及侵袭 [J ] . 标记免疫分析与临床 , 2021 , 28 ( 4 ): 577 - 582 .
LAI X , FAN Y N , WANG R F . LINC01106 affects the proliferation, migration and invasion of breast cancer MDA-MB-231 cells by targeting miR-744-5p [J ] . Labeled Immunoass Clin Med , 2021 , 28 ( 4 ): 577 - 582 .
YU Y , LUO W , YANG Z J , et al . miR-190 suppresses breast cancer metastasis by regulation of TGF-&#x003b2;-induced epithelial-mesenchymal transition [J ] . Mol Cancer , 2018 , 17 ( 1 ): 70 . DOI: 10.1186/s12943-018-0818-9 http://doi.org/10.1186/s12943-018-0818-9
ZHENG J J , QUE Q Y , XU H T , et al . Hypoxia activates SOX5/Wnt/&#x003b2;-catenin signaling by suppressing miR-338-3p in gastric cancer [J ] . Technol Cancer Res Treat , 2020 , 19 : 1533033820905825.
ZHANG L , DING F P . Hsa_circ_0008945 promoted breast cancer progression by targeting miR-338-3p [J ] . Onco Targets Ther , 2019 , 12 : 6577 - 6589 . DOI: 10.2147/OTT.S213994 http://doi.org/10.2147/OTT.S213994 https://www.dovepress.com/hsacirc0008945-promoted-breast-cancer-progression-by-targeting-mir-338-peer-reviewed-article-OTT https://www.dovepress.com/hsacirc0008945-promoted-breast-cancer-progression-by-targeting-mir-338-peer-reviewed-article-OTT
DUAN X , GUO G C , PEI X H , et al . Baicalin inhibits cell viability, migration and invasion in breast cancer by regulating miR-338-3p and MORC4 [J ] . Onco Targets Ther , 2019 , 12 : 11183 - 11193 . DOI: 10.2147/OTT.S217101 http://doi.org/10.2147/OTT.S217101 https://www.dovepress.com/baicalin-inhibits-cell-viability-migration-and-invasion-in-breast-canc-peer-reviewed-article-OTT https://www.dovepress.com/baicalin-inhibits-cell-viability-migration-and-invasion-in-breast-canc-peer-reviewed-article-OTT
0
Views
2232
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621